Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Opłaty publikacyjne
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
1/2024
vol. 126 streszczenie artykułu:
Opis przypadku
Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
Agnieszka Nowosielska
1
,
Tomasz Wójtowicz
1
,
Emilija Narvydaitė
2
KLINIKA OCZNA 2024, 126, 1: 39-44
Data publikacji online: 2024/03/26
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Aim of the study To evaluate the outcome of pars plana vitrectomy, subretinal injection of tissue plasminogen activator (tPA), and intraocular injection of anti-VEGF (vascular endothelial growth factor) bevacizumab (Avastin) injection in patients with submacular haemorrhage (SMH) secondary to wet age-related macular degeneration (AMD). Material and methods Retrospective chart review of 10 patients who underwent vitrectomy, subretinal tPA (concentration 12.5 μg/0.1 ml), anti-VEGF bevacizumab injection into the vitreous cavity and partial fluid-air exchange due to SMH in wet AMD. Results Ten patients (6 female and 4 male) with SMH secondary to wet AMD were enrolled in the study. All the patients were operated on by the same surgeon and the same procedure was followed. The surgery was performed between day 7 and day 42 (mean 19.6 days) after the onset of the haemorrhage. Preoperative visual acuity (VA) was low, between hand movement (HM) and counting fingers (CF). All the patients experienced VA improvement, ranging from 0.05 to 0.8, after surgery. The observation period was a minimum of 6 months. After the surgery patients were put on regular treatment of wet AMD with anti-VEGF. Conclusions Surgical intervention – vitrectomy, subretinal tPA injection, anti-VEGF injection into the vitreous cavity and partial fluid-air exchange – is an effective procedure to achieve visual acuity improvement in cases of SMH secondary to wet AMD, even if performed late. No severe complications of the surgery were noted. |
|